Tag Archives: Foreign direct investment

Multinationals and Monopolies: Pharmaceutical Industry in India after TRIPS

One of the basic apprehensions of the re-introduction of product patent protection in pharmaceuticals in India has been that product monopolies will lead to very high prices. While high prices have been reported from time to time, no systematic studies were available. This … Continue reading

Posted in Drug Pricing, Generic drug, patent, Sec 3 (d), TRIPS | Tagged , | 2 Comments

BIT(s) by bit

by Shalini Bhutani | November 09, 2011 Source: mylaw.net Bilateral investment treaties (“BITs”) and other free trade agreements (“FTAs”) have emerged as the way forward for countries to craft their trade and economic relations. BITs are intended to facilitate the … Continue reading

Posted in BITS, EU-India FTA | Tagged , , | Leave a comment

Industry ministry opposes allowing brownfield investment through auto route

NEW DELHI: The Department of Industrial Policy and Promotion has raised serious doubts on the suitability of India’s competition authority to oversee acquisition of local firms by multinational drug companies. In a note of dissent addressed to the High Level … Continue reading

Posted in Compulsory Licensing, Mergers and Acquisitions | Tagged , , , , | Leave a comment

Sharma writes to PM on pharma M&A concerns

Minister seeks ‘procedural filter’ on investments by foreign companies in Indian pharmaceutical firms Asit Ranjan Mishra The Livemint, 21 September 2011 India’s commerce and industry ministry is getting serious with its effort to have all foreign investment in Indian pharmaceutical … Continue reading

Posted in FDI, Mergers and Acquisitions | Tagged , , | Leave a comment

Indian industry warns of ‘incapacitating’ effect of large foreign takeovers

Scrip Magazine 30 August 2011 Anju Ghangurde Second rung Indian firms, which account for less than 20% of the country’s pharmaceutical exports, cannot fill the shoes of first tier companies if the latter continue to be acquired by foreign firms, … Continue reading

Posted in Compulsory Licensing, FDI, Generic drug, Mergers and Acquisitions, seizures, TRIPS | Tagged , , , | 1 Comment

Planning Commission endorses 100% FDI in pharmaceutical sector

Industry groups backed by domestic players have been seeking restrictions on mergers and acquisitions arguing that India would turn into a contract manufacturing centre and would lose its edge. Another concern is that prices of medicines will increase due to lack of … Continue reading

Posted in FDI, Generic drug | Tagged , | Leave a comment